OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neuro-Oncology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review	65
Focused versus conventional radiotherapy in spinal oncology: is there any difference in fusion rates and pseudoarthrosis?	52
The trial effect in patients with glioblastoma: effect of clinical trial enrollment on overall survival	51
Factors influencing timely diagnosis in neurolymphomatosis	45
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	45
Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection	42
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population	42
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma	41
Prognostic factors among patients with brain metastases from cancer of unknown primary site	40
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease	38
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence	38
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study	36
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas	34
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy	32
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannoma	31
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update	31
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu	30
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases	30
Accelerated hyper-versus normofractionated radiochemotherapy with temozolomide in patients with glioblastoma: a multicenter retrospective analysis	29
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities	29
Panobinostat in adults with H3 K27M-mutant diffuse midline glioma: a single-center experience	29
Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review	28
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas	28
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor	28
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival	27

A practical guide to neuro-oncology fellowship	27
Glioblastoma cell motility and invasion is regulated by membrane-associated heat shock protein Hsp70	26
MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma	26
Efficacy of endoscopic management of primary central nervous system lymphoma: a multicentric study and literature review	26
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases	26